Back to results
US 2008/0287690 A1Published application
Process For (3R, 5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4- [(4-Hydroxy Methyl Phenyl Amino) Carbonyl]-Pyrrol-1-Yl]-3,5-Dihydroxy-Heptanoic Acid Hemi Calcium Salt
AssigneeRanbaxy Laboratories Limited
InventorsVijay Kaul, Gyan Chand Yadav
Life of this patent
Estimating the term…
Abstract
The present invention relates to processes for the manufacture of (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt.
Claims10
A method of making 3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt of Formula I,
- pharmaceutically acceptable salts, pharmaceutically acceptable solvates, polymorphs, pro-drugs, stereoisomers, tautomeric forms, N-oxides and metabolites thereof, the method comprising:
- (a) reacting a compound of Formula II with a compound of Formula III,
- to form a compound of Formula of IV (wherein R is alkyl, aryl or arylalkyl);
- (b) reacting the compound of Formula IV with benzaldehyde to form a compound of Formula V;
- (c) reacting the compound of Formula V with 4-fluorobenzaldehyde to form a compound of Formula VI;
- (d) reacting the compound of Formula VI with a compound of Formula VII,
- to form the compound of Formula VIII;
- (e) deprotecting the compound of Formula VIII to form a compound of Formula IX;
- (f) reducing the compound of Formula IX to form a compound of Formula X;
- (g) deprotecting the compound of Formula X to form a compound of Formula XI;
- and
- (h) converting the compound of Formula XI to compound of Formula I,
- wherein any purification of products of the steps (a) to (h) is carried out without using column chromatography, and the reaction in step (h) involves a one-pot conversion of compound of Formula XI to the calcium salt of Formula I.
10 more elements
Dependencies are inferred from the claim text.